VBIV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
VBIV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-04-29), VBI Vaccines's current share price is $0.5769. VBI Vaccines's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $0.59. VBI Vaccines's Cyclically Adjusted PS Ratio for today is 0.98.
The historical rank and industry rank for VBI Vaccines's Cyclically Adjusted PS Ratio or its related term are showing as below:
During the past years, VBI Vaccines's highest Cyclically Adjusted PS Ratio was 384.38. The lowest was 0.85. And the median was 118.27.
VBIV's Cyclically Adjusted PS Ratio is ranked better thanThe Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
VBI Vaccines's adjusted revenue per share data for the three months ended in Dec. 2023 was $0.036. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.59 for the trailing ten years ended in Dec. 2023.
The historical data trend for VBI Vaccines's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VBI Vaccines Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Cyclically Adjusted PS Ratio | Get a 7-Day Free Trial | 19.92 | 15.49 | 5.62 | 1.09 | 0.99 |
For the Biotechnology subindustry, VBI Vaccines's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, VBI Vaccines's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where VBI Vaccines's Cyclically Adjusted PS Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
VBI Vaccines's Cyclically Adjusted PS Ratio for today is calculated as
Cyclically Adjusted PS Ratio | = | Share Price | / | Cyclically Adjusted Revenue per Share |
= | 0.5769 | / | 0.59 | |
= | 0.98 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VBI Vaccines's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:
For example, VBI Vaccines's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:
Adj_RevenuePerShare | = | Revenue per Share | / | CPI of Dec. 2023 (Change) | * | Current CPI (Dec. 2023) |
= | 0.036 | / | 129.4194 | * | 129.4194 | |
= | 0.036 |
Current CPI (Dec. 2023) = 129.4194.
VBI Vaccines Quarterly Data
Revenue per Share | CPI | Adj_RevenuePerShare | |
201403 | 0.000 | 99.695 | 0.000 |
201406 | 0.000 | 100.560 | 0.000 |
201409 | 0.000 | 100.428 | 0.000 |
201412 | 0.000 | 99.070 | 0.000 |
201503 | 0.000 | 99.621 | 0.000 |
201506 | 0.000 | 100.684 | 0.000 |
201509 | 0.227 | 100.392 | 0.293 |
201512 | -0.016 | 99.792 | -0.021 |
201603 | 0.076 | 100.470 | 0.098 |
201606 | 0.089 | 101.688 | 0.113 |
201609 | 0.233 | 101.861 | 0.296 |
201612 | 0.110 | 101.863 | 0.140 |
201703 | 0.095 | 102.862 | 0.120 |
201706 | 0.257 | 103.349 | 0.322 |
201709 | 0.144 | 104.136 | 0.179 |
201712 | 0.107 | 104.011 | 0.133 |
201803 | 0.083 | 105.290 | 0.102 |
201806 | 0.109 | 106.317 | 0.133 |
201809 | 0.121 | 106.507 | 0.147 |
201812 | 1.154 | 105.998 | 1.409 |
201903 | 0.111 | 107.251 | 0.134 |
201906 | 0.197 | 108.070 | 0.236 |
201909 | 0.184 | 108.329 | 0.220 |
201912 | 0.096 | 108.420 | 0.115 |
202003 | 0.070 | 108.902 | 0.083 |
202006 | 0.025 | 108.767 | 0.030 |
202009 | 0.038 | 109.815 | 0.045 |
202012 | 0.020 | 109.897 | 0.024 |
202103 | 0.036 | 111.754 | 0.042 |
202106 | 0.017 | 114.631 | 0.019 |
202109 | 0.013 | 115.734 | 0.015 |
202112 | 0.009 | 117.630 | 0.010 |
202203 | 0.015 | 121.301 | 0.016 |
202206 | 0.040 | 125.017 | 0.041 |
202209 | 0.037 | 125.227 | 0.038 |
202212 | 0.034 | 125.222 | 0.035 |
202303 | 0.056 | 127.348 | 0.057 |
202306 | 0.084 | 128.729 | 0.084 |
202309 | 0.313 | 129.860 | 0.312 |
202312 | 0.036 | 129.419 | 0.036 |
Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Thank you for viewing the detailed overview of VBI Vaccines's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Steven Gillis | director | 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO IL 60631 |
Vaughn B Himes | director | C/O SEATTLE GENETICS, INC., 21823 30TH DRIVE SE, BOTHELL WA 98021 |
Perceptive Life Sciences Master Fund Ltd | 10 percent owner | C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003 |
John Robert Dillman | officer: Chief Commercial Officer | C/O VBI VACCINES INC., 160 SECOND STREET, FLOOR 3, CAMBRIDGE MA 02142 |
Nell Beattie | officer: Director, Corp Development/IR | 222 THIRD STREET, SUITE 2241, CAMBRIDGE MA 02142 |
Linda Bain | director | C/O BLUEBIRD BIO, INC., 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139 |
Damian Braga | director | 222 THIRD STREET, SUITE 2241, CAMBRIDGE MA 02142 |
Francisco Diaz-mitoma | officer: Chief Medical Officer | 222 THIRD STREET, SUITE 2241, CAMBRIDGE MA 02142 |
Christopher Mcnulty | officer: CFO and Head of BD | C/O INVIVO THERAPEUTICS HOLDINGS CORP., 1 KENDALL SQUARE, SUITE B14402, CAMBRIDGE MA 02139 |
Jeff Baxter | director, officer: President and CEO | C/O VBI VACCINES INC.,, 222 THIRD STREET, STE 2241, CAMBRIDGE MA 02142 |
Joanne Cordeiro | director | 171 SWANTON STREET, UNIT 48, WINCHESTER MA 01890 |
Blaine H. Mckee | director | C/O HART, 84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON MA 01746 |
Tomer Kariv | director | C/O ARNO THERAPEUTICS, INC., 200 ROUTE 31 NORTH, SUITE 104, FLEMINGTON NJ 08822 |
Joseph Edelman | 10 percent owner | C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003 |
Perceptive Advisors Llc | 10 percent owner | 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003 |
From GuruFocus
By Business Wire Business Wire • 02-23-2023
By Business Wire • 09-27-2023
By Business Wire • 07-24-2023
By Business Wire • 07-19-2023
By Business Wire Business Wire • 04-25-2023
By Business Wire • 07-05-2023
By Business Wire • 06-23-2023
By Business Wire • 11-20-2023
By Business Wire Business Wire • 06-28-2022
By Business Wire Business Wire • 06-06-2022